ISLR and neoplasm: In syngeneic murine tumor models generated by subcutaneously or orthotopically implanting the murine PDAC cell line mT5, oral administration of Am80 increased the number of Meflin+ CAFs, accompanied by a decrease in tumor stiffness and increases in tumor vessel area and intratumoral delivery of the chemotherapeutic agent gemcitabine [24].